{"brief_title": "Cocaine-Metyrapone Interaction Study - 1", "brief_summary": "The purpose of this study is to examine the safety of two consecutive days of metyrapone (MRP) in subjects who may use cocaine concurrently.", "detailed_description": "To evaluate the safety of metyrapone (MRP) for using in an outpatient study in which participants would be given 2 750 mg doses of MRP per week. Secondary study goals are to evaluate the possible efficacy of MRP as a treatment for cocaine dependence and to compare 3 factors hypothesized to induce cocaine craving: cocaine cues, stress, and cocaine itself. This study will utilize a Double Blind, placebo-controlled crossover design with 3 factors: 1) medication 2) relapse trigger and 3) infusion for an 11 day in-patient treatment.", "condition": "Infusions, Intravenous", "intervention_type": "Drug", "intervention_name": "Metyrapone", "criteria": "Inclusion Criteria: Male or Females between 18 and 45 yrs of age; cocaine dependence according to DSM-4; females of child-bearing potential must test non-pregnant and use adequate birth control; be able to provide consent, comply with protocol requirements and try to complete all study treatments. Exclusion Criteria: Additional criteria available during screening at the site.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "45 Years", "healthy_volunteers": "No", "id": "NCT00033098.xml"}